Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations

被引：8
|
作者：
Oak, Jean S. [1 ]
Ohgami, Robert S. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2017年 / 33卷 / 04期
关键词：
LEUKEMIA; GENES;
D O I：
10.1080/03007995.2017.1284049
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：781 / 782
页数：2
相关论文
共 50 条
  • [21] Spectrum of Gene Mutations and Clinical Significance in Myeloid Malignancies Patients with ASXL1 Mutations
    Bai, Jie
    Teng, Guangshuai
    Wang, Yingshao
    Xu, Jing
    Du, Chenxiao
    Wang, Yan
    Chen, Yafang
    Sheng, Mengyao
    Bai, Jiaojiao
    Zhang, Lei
    Zhou, Yuan
    Yang, Feng-Chun
    BLOOD, 2018, 132
  • [22] ASXL2 Is Required for Normal Hematopoiesis and Loss of asxl2 Leads to Myeloid Malignancies in Mice
    Li, Jianping
    He, Fuhong
    Zhang, Peng
    Chen, Shi
    Shi, Hui
    Sun, Yanling
    Ying, Guo
    Yang, Hui
    Nimer, Stephen D.
    Wang, Qian-Fei
    Xu, Mingjiang
    Yang, Feng-Chun
    BLOOD, 2016, 128 (22)
  • [23] ASXL1 and ASXL2 Complementarily Maintain PR-DUB Activity to Promote Survival of Myeloid Leukemogenesis.
    Takeda, Reina
    Asada, Shuhei
    Goyama, Susumu
    Kitamura, Toshio
    CANCER SCIENCE, 2022, 113 : 1274 - 1274
  • [24] TET2 and ASXL1 Mutations in Leukemic Transformation of Chronic Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Patel, Jay
    Harris, Kelly
    Yao, Jin Juan
    Hedvat, Cyrus V.
    Heguy, Adriana
    Bueso-Ramos, Carlos
    Kantarjian, Hagop M.
    Levine, Ross L.
    Verstovsek, Srdan
    BLOOD, 2009, 114 (22) : 1130 - 1131
  • [25] Mutations of ASXL1 and TET2 in aplastic anemia
    Huang, Jinbo
    Ge, Meili
    Lu, Shihong
    Shi, Jun
    Li, Xingxin
    Zhang, Jizhou
    Wang, Min
    Yu, Wei
    Shao, Yingqi
    Huang, Zhendong
    Zhang, Jing
    Nie, Neng
    Zheng, Yizhou
    HAEMATOLOGICA, 2015, 100 (05)
  • [26] ASXL1 mutations in Chinese patients with essential thrombocythemia
    Nie, Yan-Bo
    Sun, Meng
    He, Colin K.
    Ju, Man-Kai
    Zhou, Fu-Ling
    Wu, San-Yun
    Zhou, Yi
    Liu, Li
    Shen, Hui
    Huang, Ting-Ting
    Liu, Pan
    Xu, Ying
    Shao, Liang
    Zuo, Xue-Lan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (05) : 4149 - 4156
  • [27] Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms
    Collinsa, Taylor B.
    Laranjeiraa, Angelo B. A.
    Konga, Tim
    Fulbrighta, Mary C.
    Fishera, Daniel A. C.
    Sturgeona, Christopher M.
    Batistaa, Luis F. Z.
    Oh, Stephen T.
    EXPERIMENTAL HEMATOLOGY, 2024, 132
  • [28] Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia
    Braun, Theodore
    Foley, Amy
    Druker, Brian J.
    Maxson, Julia E.
    BLOOD, 2018, 132
  • [29] ASXL1 mutations in idiopathic cytopenias: determined significance?
    Galvez, Carlos
    Stein, Brady L.
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 568 - 570
  • [30] PROGNOSTIC SIGNIFICANT OF ASXL1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES
    Wang, S. Y.
    Lin, Y.
    Zheng, Y.
    Wang, Z. C.
    HAEMATOLOGICA, 2016, 101 : 501 - 501
12345